当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
标题(英文)
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
条件
Advanced Hepatocellular Carcinoma|BCLC Stage B Hepatocellular Carcinoma|BCLC Stage C Hepatocellular Carcinoma
干预
Drug: Cabozantinib S-malate|Biological: Pembrolizumab